Participated · Series B · Jun 2020

MediBuddy is an Indian digital healthcare platform operating in the healthtech space. The company offers digital healthcare services. It announced it has secured $18 million in funding. The capital came from existing investors Quadria Capital, Lightrock and TEAMFund. The announcement did not disclose the financing instrument, valuation, or operating metrics such as revenue or user counts. No additional future plans or transaction terms were provided in the report. MediBuddy is an end-to-end digital healthcare platform that provides 24x7 access to specialist doctors via video calls, doorstep medicine delivery, at-home lab tests, mental health support and other integrated services. Led by CEO Satish Kannan and based in Bangalore, the platform has catered to the healthcare needs of over 3 crore Indians. The company’s core product integrates telemedicine, diagnostics and pharmacy fulfillment into a single user experience. Following the Series C, MediBuddy plans to invest in customer awareness and hiring. It also intends to strengthen its technology platforms, including data science capabilities, and to fund clinical research and product development. MediBuddy is a digital healthcare platform with a partner network comprising doctors, hospitals, diagnostic centres and pharmacies across India. The company raised Rs 25 crore in a venture debt round led by Stride Ventures. MediBuddy will use the funds to further strengthen its technology, operations and marketing. The financing came as venture debt, not equity. Stride Ventures is a venture debt fund that recently launched its second fund with a target corpus of over Rs 1,000 crore and has disbursed over Rs 200 crore since January. The company operates in the Indian digital healthcare market. MediBuddy is a digital healthcare platform. The company announced it has closed a $40 million Series B funding round. The financing was led by India Life Sciences Fund III, LLC. The round included participation from other, unnamed investors. The announcement was reported in India and provided no additional operational or revenue metrics. No further details on use of proceeds or prior rounds were disclosed in the article. MediBuddy DocsApp, formed by the merger of Bengaluru-based DocsApp and MediBuddy, is a digital healthcare platform providing online specialist doctor consultations, lab tests, preventive health checks and medicine delivery. The joint entity serves over three crore Indians via a partner network of more than 90,000 doctors, 7,000 hospitals, 3,000 diagnostic centres and 2,500 pharmacies, covering over 95% of Indian pin codes. It targets both enterprise and retail customers and aims to deliver an on-demand healthcare platform with strong customer experience. The company plans to use new funding to strengthen its doctor base, patient reach, product, and technology. Leadership said the merger will help establish market leadership and advance the mission of providing high-quality healthcare to a billion people.

Participated · Series B · Jun 2020

DocsApp operates an online doctor consultation platform and merged with digital consumer health business MediBuddy in a mixed cash-and-equity deal while continuing to run as a separate entity. The combined entity has raised a $20 million Series B to bolster doctor supply, patient reach, product and technology and expand its direct-to-consumer business. DocsApp was founded in 2015 by Satish Kannan and D Enbasekar and previously acquired patient-doctor engagement platform DocWise in August 2019. Post-merger the entity projects a customer base of three crores and a provider network of about 90,000 doctors, 7,000 hospitals, 3,000 diagnostic centres and 2,500 pharmacies. The company declined to disclose the ultimate holding-company arrangement pending completion of formalities. Bessemer is a common investor across the merged businesses. Phasorz Technologies operates DocsApp, a mobile doctor-consultation app launched in July 2015. DocsApp lets users upload symptoms and diagnostic reports, pay a consultation fee, and get one-on-one consultations via video call, voice call or in-built chat. The platform also supports ordering medicines and booking diagnostic tests online and offers consultations across 15 specialties including dermatology, gynecology and pediatrics. The company says it has onboarded more than 5,000 specialist doctors (up from 2,000 at its 2017 Series A) and claims around 6 million registered users across Tier-1 and smaller urban Tier-2 areas. Founded in 2013 by Satish Kannan and Enbasekar D., Phasorz is backed by investors including Bessemer Venture Partners, GSF Accelerator, Vijay Shekhar Sharma, Anupam Mittal and Srikanth Sundararajan. The company recently raised debt financing to support further growth, with the lead investor saying the funding will give DocsApp a fillip to scale. Phasorz Technologies operates DocsApp, a mobile-first doctor consultation platform that connects patients with specialist doctors for one-on-one chats or calls and supports medicine orders and diagnostic bookings. The platform on-boards only specialist doctors and aims to match patients with the right doctor in under 30 minutes after users upload symptoms and pay a consultation fee. DocsApp reports over 2,000 registered doctors across specialties including dermatology, gynaecology, paediatrics, psychiatry and general medicine. The Bengaluru-based company was founded in 2013 and launched DocsApp in July 2015. Management says it will use new funding for hiring, expanding operations, product development and outreach to recruit more doctors and extend services into remote and under-penetrated areas. The app previously raised $1.2 million and has backing from accelerators and angels. DocsApp is a Bangalore-based medical consultation app founded in 2015 by Satish Kannan and Enbasekar D. The platform lets patients chat with doctors and share images and reports across specialties including General Medicine, Gynecology, Psychiatry, Pediatrics, Weight Management, Sexology and Gastroenterology. The app is available for Android and iOS and has been downloaded more than 80,000 times. DocsApp is currently used by more than 15,000 patients every month from New Delhi, Bengaluru, Chennai, NCR, Mumbai, and Hyderabad. The company raised $1.2M in seed funding from Rebright Partners and angel investors Anand Rajaraman and Venky Harinarayan.

Participated · Equity · Mar 2019

Aibono is an AI-driven platform that supplies small-scale farmers with sensors and analytic software to predict harvest volumes 60–90 days in advance and help sync supply with retailer demand in real time. The platform processes food consumption data and works with both farmers and retailers to optimize sourcing, transport and pricing, aiming to reduce post-harvest losses. The company targets higher price realization for farmers while reducing inconsistent supply of fresh produce to consumers. Aibono was founded in 2014 by IIT Madras graduate Vivek Rajkumar and operates out of India with plans to expand further in South India and into additional Tier 1 and Tier 2 cities. The business aims to scale its network to 2,000 farmers and 1,000 retailers using the newly raised capital. Financially, the company completed an early-stage seed raise to support this strategic growth.

Participated · Seed · Sep 2017

Passage AI develops AI-powered conversational interfaces and a no-code bot-building tool that can be deployed anywhere in as little as two weeks. Its deep learning model understands natural language text and speech to identify intents, extract pertinent information, respond to queries, and search large datasets. Founded in 2016 by Madhu Mathihalli, Ravi Raj and Mitul Tiwari, the company is based in Mountain View, CA. Passage AI targets retail, telecommunications, automotive and education industries to automate routine tasks and provide instantaneous responses to common questions. The company raised $7.3M in a Series A led by Blumberg Capital, bringing total funding to $10.3M. Bruce Taragin of Blumberg Capital will join Passage AI’s board as part of the investment. Passage plans to use the proceeds to expand into additional industries and international markets. Passage.AI builds AI-enabled conversational interfaces that let businesses automate and improve customer interactions across messaging and voice platforms. Its chatbot responds to customer messages by querying content using an NLP platform. The technology is available for platforms including Facebook Messenger, Slack, SMS, Amazon Alexa and Google Home. Passage.AI's solutions are deployed by enterprises such as Kohl’s and educational organizations including Udacity. The company was founded in 2016 by WalmartLabs alumni Madhu Mathihalli and Ravi Raj, and LinkedIn alumnus Mitul Tiwari. Passage.AI raised $3M in funding, providing capital to support its product and deployments.

Led · Series A · Jun 2016

Trooly applies machine learning to public and dark-web digital footprints to produce a 30-second scorecard that verifies identity, screens prior behavior, and predicts future antisocial or pro-social behavior. Its platform links partial and messy public records, runs confidence scores, and distinguishes between major/minor and recent/non-recent offenses. The service returns an assessment in roughly two-thirds of requests, reports a "virtually zero" probability of failed background checks in about half of cases, and sees negative hits in about 8% of checks. Trooly has built dark-web crawlers, in-house indexes of offender registers, and licenses public-record datasets for its North American markets. Customers are in the single digits and production service has been live since August of last year; it is working with one major sharing-economy customer and is piloting with financial-services firms. The company is targeting broader financial-services use cases (KYC, AML, thin-file lending) and plans product development and scaling informed by those pilots.